SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-033866
Filing Date
2024-08-26
Accepted
2024-08-26 16:05:13
Documents
15
Period of Report
2024-08-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43427
2 ex4-1.htm EX-4.1 84691
3 ex10-1.htm EX-10.1 42755
  Complete submission text file 0001493152-24-033866.txt   369748

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE orgs-20240821.xsd EX-101.SCH 3018
5 XBRL LABEL FILE orgs-20240821_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE orgs-20240821_pre.xml EX-101.PRE 22361
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3535
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38416 | Film No.: 241241175
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)